ARCHIVES

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.

January 26, 2001

Three New RFAs Announced In Cancer Control

November 3, 1978

In Brief: Senate Bill Would Give NCI $1.034 Billion In 1982, $45 Million (3.5 Percent) More Than FY 1981 Budget

September 25, 1981

Report on Carcinogens: Advisors Recommend Tobacco, UV Light, Tamoxifen, For Report

November 7, 1997

Nomograms 66% Correct In Predicting Outcome For Brachytherapy, Study Finds

September 28, 2001

Cancer Advocates Ask House By Byspass Budget; NCCR’s Day Calls For $380 Mil. Minimum Increase

March 12, 1993